Simplify's take
What believers are saying
- Similarweb named DrAnsay Germany’s fastest-growing health platform in January 2026.
- September 2026 survey support for medical cannabis gives DrAnsay political ammunition.
- September 1, 2026 Wegovy tablet launch expands weight-loss telemedicine beyond cannabis and sick notes.
What critics are saying
- Landgericht Düsseldorf ruled April 23, 2026, against DrAnsay-linked cannabis pharmacy practices.
- Bundestag’s pending cannabis bill since December 2025 threatens telemedicine-first prescribing and mail delivery.
- A failed regulatory appeal or injunction cascade could cripple its cannabis revenue engine.
What makes DrAnsay unique
- DrAnsay built Germany’s remote-care brand, claiming three million treatments since 2018.
- It self-finances, avoiding venture dilution and investor pressure on telemedicine strategy.
- ISO 27001 certification strengthens its regulated-health positioning and security story.
Help us improve and share your feedback! Did you find this helpful?